MAINZ BIOMED N.V. EO 1MAINZ BIOMED N.V. EO 1MAINZ BIOMED N.V. EO 1

MAINZ BIOMED N.V. EO 1

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.96 M‬EUR
‪−20.91 M‬EUR
‪863.58 K‬EUR
‪2.89 M‬
Beta (1Y)
0.86
Employees (FY)
26
Change (1Y)
−45 −63.38%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About Mainz Biomed N.V.


CEO
Guido Baechler
Headquarters
Mainz
Founded
2021
ISIN
NL0015000LC2
FIGI
BBG013CRNFH2
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 4TO.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MAINZ BIOMED N.V. EO 1 stocks are traded under the ticker 4TO.
We've gathered analysts' opinions on MAINZ BIOMED N.V. EO 1 future price: according to them, 4TO price has a max estimate of 14.82 EUR and a min estimate of 14.82 EUR. Watch 4TO chart and read a more detailed MAINZ BIOMED N.V. EO 1 stock forecast: see what analysts think of MAINZ BIOMED N.V. EO 1 and suggest that you do with its stocks.
4TO reached its all-time high on Jan 18, 2022 with the price of 1,056.0000 EUR, and its all-time low was 6.0000 EUR and was reached on Sep 25, 2024. View more price dynamics on 4TO chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track MAINZ BIOMED N.V. EO 1 financials in yearly and quarterly reports right on TradingView.
MAINZ BIOMED N.V. EO 1 is going to release the next earnings report on May 14, 2025. Keep track of upcoming events with our Earnings Calendar.
MAINZ BIOMED N.V. EO 1 revenue for the last quarter amounts to ‪513.12 K‬ EUR, despite the estimated figure of ‪513.12 K‬ EUR. In the next quarter, revenue is expected to reach ‪277.30 K‬ EUR.
No, 4TO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 14, 2025, the company has 26 employees. See our rating of the largest employees — is MAINZ BIOMED N.V. EO 1 on this list?
Like other stocks, 4TO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MAINZ BIOMED N.V. EO 1 stock right from TradingView charts — choose your broker and connect to your account.